| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 39,8 k € | -61.6% | 103,6 k € | +816.3% | -14,5 k € | -159.9% | 24,1 k € | |
| EBITDA | -210,6 k € | -408.8% | 68,2 k € | +468.0% | -18,5 k € | -181.4% | 22,8 k € | |
| Operating profit | -244,9 k € | -666.3% | 43,2 k € | +307.2% | -20,9 k € | -192.9% | 22,5 k € | |
| Profit/loss | -269,8 k € | -1101.7% | 26,9 k € | +212.1% | -24,0 k € | -207.0% | 22,5 k € | |
| Equity | -244,4 k € | -1064.1% | 25,4 k € | +1704.4% | -1,6 k € | -107.0% | 22,5 k € | |
| Total assets | 629,3 k € | -20.4% | 790,6 k € | +6813.1% | 11,4 k € | -68.1% | 35,9 k € | |
| Cash | 395,3 € | -94.1% | 6,7 k € | +583.1% | 985,6 € | -93.5% | 15,3 k € | |
| Debts | 871,5 k € | +13.9% | 764,9 k € | +5776.3% | 13,0 k € | -3.2% | 13,5 k € | |
Private limited company · Verviers · incorporated on 17/06/2022
Private limited company loss-making in the latest fiscal year. Cash position declining (-94.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMA FUTUR is a Private limited company incorporated in 2022. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Verviers.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette